ResMed (RMD)
(Delayed Data from NYSE)
$210.91 USD
-0.65 (-0.31%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $210.93 +0.02 (0.01%) 7:58 PM ET
1-Strong Buy of 5 1
D Value B Growth D Momentum C VGM
Brokerage Reports
ResMed Inc. [RMD]
Reports for Purchase
Showing records 521 - 528 ( 528 total )
Company: ResMed Inc.
Industry: Medical - Products
STOCKS WITH EXCEPTIONAL APPRECIATION OPPORTUNITY ONCE THE OVERALL MARKET STABILIZES
Provider: FELTL & COMPANY
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Survey data and currency movements suggest modest Q4 upside
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: ResMed Inc.
Industry: Medical - Products
UnitedHealthcare: Go home, use APAP - New coverage policy positive for ResMed
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: ResMed Inc.
Industry: Medical - Products
BiancaMed acquisition smart move, despite near-term dilution
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Acquires BiancaMed and new AASM sleep testing legislative effort.
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: ResMed Inc.
Industry: Medical - Products
Wake Up - skip the snooze button with a STRONG BUY, $40.40 PT
Provider: FELTL & COMPANY
Analyst: HAYNOR B